NIH-funded research Fellowship grant

How changes in a brain receptor affect alcohol dependence

Official title: Receptor variant-based changes in the role of PACAP in the nucleus accumbens during the transition to ethanol dependence

Funded at Drexel University · NIH-10928161 · Data updated 2026-11-12

This study is looking at how a brain chemical called PACAP changes when someone becomes dependent on alcohol, using animal models to help us understand why some people drink more when they’re dependent, which could help find new ways to treat alcohol use problems.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionDrexel University
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2026
Funding year2024
Award (this year)$48,974
NIH project number5F31AA031427-02
Project IDNIH-10928161 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research would be individuals struggling with alcohol dependence or those at risk of developing alcohol use disorders.

Less likely to help

Patients who do not consume alcohol or have no history of alcohol dependence may not benefit from this research.

What this research studies

This research investigates how the role of a specific neuropeptide, PACAP, changes in the brain during the transition to alcohol dependence. It focuses on the paraventricular nucleus of the thalamus and its connection to the nucleus accumbens, examining how different drinking histories can alter the effects of PACAP on alcohol consumption. By using animal models, the study aims to understand the mechanisms behind increased alcohol intake in dependent states, which could lead to new treatment strategies for alcohol use disorders.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic approaches for treating alcohol dependence.

How similar studies have gone: Previous research has shown promising results in understanding the role of neuropeptides in addiction, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Drexel University
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Carpenter, Brody Allen — Drexel University
  • Study coordinator: Carpenter, Brody Allen

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.